Obstetrics & Gynecology Doctors in Palmer, AK Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Christy Dawn South, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2490 S Woodworth Loop Ste 301, Palmer, AK 99645 Phone: 907-746-7747    Fax: 907-746-7731

Dr. Cassandra Rae Cook, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Mat-su Women's Health Specialists, 2490 S. Woodworth Loop Suite 301, Palmer, AK 99645 Phone: 907-746-7747    Fax: 907-746-7731

Dr. John David Houghton, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2490 S Woodworth Loop Ste 301, Palmer, AK 99645 Phone: 907-746-7747    Fax: 907-746-7740

Susan M Lemagie, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 425 E Dahlia Ave, Suite J, Palmer, AK 99645 Phone: 907-745-8379

News Archive

High-content screening as a universal tool for fingerprinting of vytotoxicity of nanoparticles

As researchers develop an ever-expanding toolkit of nanoparticles for use as drug and imaging agent delivery vehicles, there is a growing need to understand how a given nanoparticle's physical and chemical properties affect biological activity and toxicity.

ARIAD Pharmaceuticals' Iclusig gets EC marketing authorization for CML and Ph+ ALL treatment

ARIAD Pharmaceuticals, Inc. today announced that the European Commission has granted a marketing authorization for Iclusig (ponatinib) as an orphan medicinal product for two indications.

New bladder control device for women

An estimated one-third of all women experience it at some point and few are willing to talk about it, but urinary incontinence affects more than 15 million Americans and 1.5 million Canadians. Now, thanks to the innovative patent of a pelvic floor muscle trainer for at-home use, women can take control of the problem.

Positive preliminary data from Protalix's taliglucerase alfa switchover trial for Gaucher disease

Protalix BioTherapeutics, Inc., announced today positive preliminary data from the first 15 patients that completed the Company's nine month, worldwide, multi-center, open-label, switchover trial of taliglucerase alfa for the treatment of Gaucher disease under a protocol cleared by the U.S. Food and Drug Administration (FDA). The data indicate that patients can safely be switched to taliglucerase alfa from imiglucerase (Cerezyme®).

Research provides deep and detailed look at how common anesthetic causes unconsciousness

In a uniquely deep and detailed look at how the commonly used anesthetic propofol causes unconsciousness, a collaboration of labs at The Picower Institute for Learning and Memory at MIT shows that as the drug takes hold in the brain, a wide swath of regions become coordinated by very slow rhythms that maintain a commensurately languid pace of neural activity.

Read more Medical News

› Verified 5 days ago